0001578563-17-000001.txt : 20170112
0001578563-17-000001.hdr.sgml : 20170112
20170112110535
ACCESSION NUMBER: 0001578563-17-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20170112
DATE AS OF CHANGE: 20170112
EFFECTIVENESS DATE: 20170112
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVENUE THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001644963
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474113275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-278245
FILM NUMBER: 17524225
BUSINESS ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: 781-652-4500
MAIL ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
D
1
primary_doc.xml
X0707
D
LIVE
0001644963
AVENUE THERAPEUTICS, INC.
2 GANSEVOORT STREET
9TH FLOOR
NEW YORK
NY
NEW YORK
10014
781-652-4500
DELAWARE
None
None
Corporation
true
2015
Lucy
Lu, M.D.
c/o 2 Gansevoort Street
9th Floor
New York
NY
NEW YORK
10014
Executive Officer
Director
Lindsay
A.
Rosenwald, M.D.
c/o 2 Gansevoort Street
9th Floor
New York
NY
NEW YORK
10014
Director
Neil
Herskowitz
c/o 2 Gansevoort Street
9th Floor
New York
NY
NEW YORK
10014
Director
Jeffrey
Paley, M.D.
c/o 2 Gansevoort Street
9th Floor
New York
NY
NEW YORK
10014
Director
Michael
Weiss
c/o 2 Gansevoort Street
9th Floor
New York
NY
NEW YORK
10014
Director
David
J.
Horin
c/o 2 Gansevoort Street
9th Floor
New York
NY
NEW YORK
10014
Executive Officer
Scott
A.
Raines, M.D.
c/o 2 Gansevoort Street
9th Floor
New York
NY
NEW YORK
10014
Executive Officer
Akhtar
Samad, M.D. Ph.D.
c/o 2 Gansevoort Street
9th Floor
New York,
NY
NEW YORK
10014
Director
Biotechnology
Decline to Disclose
- 06b
false
2016-12-30
false
true
false
0
WestPark Capital, Inc.
39914
WestPark Capital, Inc.
39914
126 East 56th Street
3rd Floor
New York
NY
NEW YORK
10022
All States
false
5000000
200000
4800000
false
3
10000
0
0
Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering.
false
AVENUE THERAPEUTICS, INC.
/s/ Lucy Lu, M.D.
Lucy Lu, M.D.
President and Chief Executive Officer
2017-01-06